Search - tctmd.com

Displaying 501 - 520 of 617

Sort: Relevancy | Date

News Industry News

CardioFocus' HeartLight® U.S. Pivotal Results Presented at Late-Breaking Clinical Trial Session at Heart Rhythm 2015

May 15, 2015

News Daily News

Ticagrelor More Rapidly Suppresses Platelet Activity Than Clopidogrel for Low-Risk ACS Patients During Ad Hoc PCI

Todd Neale

May 11, 2015

News Daily News

ISAR-TRIPLE Publicado: No hay Beneficio Neto durante 6 Semanas frente a 6 Meses a Tratamiento Triple

April 29, 2015

News Daily News

FDA Panel Backs Cangrelor for Use in PCI

Todd Neale

April 29, 2015

News Daily News

Study Provides Insight Into Cerebral Embolization During TAVR

April 29, 2015

News Daily News

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

April 29, 2015

News Daily News

Registry Finds No Stark Differences Between Proximal, Distal Embolic Protection in CAS

Caitlin E. Cox

April 28, 2015

News Industry News

Long-Term Data Underscore Safety And Efficacy Of The Boston Scientific S-ICD™ System

April 20, 2015

News Conference News ACC 2015

DANAMI3-PRIMULTI: Complete Revascularization Improves Outcomes for STEMI

Yael L. Maxwell

March 17, 2015

News Daily News

For CKD Patients, CABG Favored Long-term Over PCI

Yael L. Maxwell

January 28, 2015

News Daily News

For CKD Patients, CABG Favored Long-term Over PCIEn Pacientes con ERC, la CABG fue Más Favorable a Largo Plazo que la PCI

Yael L. Maxwell

January 28, 2015

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2014

Caitlin E. Cox

January 12, 2015

News Daily News

Being Refused CABG a Sign of Extra Risk for PCI Patients With Left Main, Multivessel Disease

L.A. McKeown

November 20, 2014

News Conference News TCT 2014

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

September 13, 2014

News Daily News

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

September 11, 2014

News Daily News

SYNTAX at 5 Years: CABG Holds Cost-Effectiveness Edge Over PCI

August 20, 2014

News Daily News

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

L.A. McKeown

July 03, 2014

News Daily News

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Yael L. Maxwell

June 17, 2014

News Conference News EuroPCR 2014

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Caitlin E. Cox

May 20, 2014

News Daily News

Preclinical Study Casts Doubt on Regenerative Ability of Special Cardiac Stem Cells

May 12, 2014

Advertisement

CardioFocus' HeartLight® U.S. Pivotal Results Presented at Late-Breaking Clinical Trial Session at Heart Rhythm 2015

Ticagrelor More Rapidly Suppresses Platelet Activity Than Clopidogrel for Low-Risk ACS Patients During Ad Hoc PCI

ISAR-TRIPLE Publicado: No hay Beneficio Neto durante 6 Semanas frente a 6 Meses a Tratamiento Triple

FDA Panel Backs Cangrelor for Use in PCI

Study Provides Insight Into Cerebral Embolization During TAVR

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

Registry Finds No Stark Differences Between Proximal, Distal Embolic Protection in CAS

Long-Term Data Underscore Safety And Efficacy Of The Boston Scientific S-ICD™ System

DANAMI3-PRIMULTI: Complete Revascularization Improves Outcomes for STEMI

For CKD Patients, CABG Favored Long-term Over PCI

For CKD Patients, CABG Favored Long-term Over PCIEn Pacientes con ERC, la CABG fue Más Favorable a Largo Plazo que la PCI

TCTMD’s Top 10 Most Popular News Stories for 2014

Being Refused CABG a Sign of Extra Risk for PCI Patients With Left Main, Multivessel Disease

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

SYNTAX at 5 Years: CABG Holds Cost-Effectiveness Edge Over PCI

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Preclinical Study Casts Doubt on Regenerative Ability of Special Cardiac Stem Cells

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content